Show Summary Details
Page of

Public health aspects of illicit psychoactive drug use 

Public health aspects of illicit psychoactive drug use
Chapter:
Public health aspects of illicit psychoactive drug use
Author(s):

Don Des Jarlais

, Jonathan Feelemyer

, and Deborah Hassin

DOI:
10.1093/med/9780199661756.003.0220
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 September 2019

The misuse of psychoactive drugs is a major public health problem in many countries. This chapter focuses on health-related aspects of illicit psychoactive drug use, in particular opiates such as heroin, cocaine, and amphetamine type stimulants, which cause major public health problems even if they are not on the magnitude of the problems caused by nicotine and alcohol. In the most recent World Drug Report (2012), the United Nations Office on Drugs and Crime estimated that in 2010, between 3.4% and 6.6% of the adult population (aged 15–64) used an illicit drug in the previous year. Of these, some 10–13% of drug users were considered to be problem users with drug dependence and/or drug-use disorders. Despite the modest numbers of adults who use illicit drugs, they generate many costs to society, including lost productivity, increased disability and deaths, disruption of family and other social relationships, and costs of increased law enforcement and incarceration.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.